Skip to content
★ Sign in to follow
NH

N Hirons

GlaxoSmithKline plc
Total declarations
173
Company
1
▲ Purchases (10 ops.)
€2,874
▼ Sales (5 ops.)
€799k

Latest filing published 13 May 2021 for GlaxoSmithKline plc, €312.

Filing timeline

BuySale
N Hirons

Insider track record

Disclosed buys
10
Disclosed sells
5
Signal history

Closed purchases

Market purchases
10

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

N Hirons: trading record in brief

N Hirons appears in our data through filings on GlaxoSmithKline plc shares, published by RNS (LSE). Over a trading history stretching from 11 July 2016 to 12 May 2021, the count stands at 173 filings.

On the open market, the record shows 10 purchases worth €2,874 and 5 sales worth €799k. Netting one side against the other leaves €796k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 156 share grants. In 2021 alone, the filings show no purchases and 1 sale.

Half of the purchases are above €286 and half below. Of 10 purchases, 10 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.

The newest entry dates from 13 May 2021: a share grant of €312, in GlaxoSmithKline plc. The latest purchase dates back some time: it was published 3,467 days ago, on 11 May 2017. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for notifying a trade is three business days (UK MAR). These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.

Companies and markets linked to N Hirons

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations172 total
  • ◆
    SVP, Global Ethics and ComplianceExecutivesGlaxoSmithKline plc
    268 GBP0FCA-NSM
    20 shares@ £13.407London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3974287-4
  • ◆
    SVP, Global Ethics & ComplianceExecutivesGlaxoSmithKline plc
    20,551 GBP0FCA-NSM
    1,586.857 shares@ £12.9508London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3944285-4
  • ◆
    SVP, Global Ethics and ComplianceExecutivesGlaxoSmithKline plc
    232 GBP0FCA-NSM
    18 shares@ £12.9061London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3943193-4
  • ◆
    SVP, Global Ethics & ComplianceExecutivesGlaxoSmithKline plc
    3,859 GBP0FCA-NSM
    292 shares@ £13.216London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3943052-6
  • ◆
    SVP, Global Ethics & ComplianceExecutivesGlaxoSmithKline plc
    209 GBP0FCA-NSM
    16 shares@ £13.0875London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3939649-0
  • ◆
    SVP, Global Ethics & ComplianceExecutivesGlaxoSmithKline plc
    342 GBP0FCA-NSM
    26 shares@ £13.1365London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3938809-4
  • ◆
    SVP, Global Ethics and ComplianceExecutivesGlaxoSmithKline plc
    253 GBP0FCA-NSM
    20 shares@ £12.671London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3908301-4
  • ◆
    SVP, Global Ethics and ComplianceExecutivesGlaxoSmithKline plc
    0FCA-NSM
    7,630 sharesN/AISIN GB0009252882FCA-NSM:3897443-4
  • ▼
    SVP, Global Ethics and ComplianceExecutivesGlaxoSmithKline plc
    43,595 GBP0FCA-NSM
    3,599 shares@ £12.1132N/AISIN GB0009252882FCA-NSM:3897443-5
  • ◆
    SVP, Global Ethics and ComplianceExecutivesGlaxoSmithKline plc
    0FCA-NSM
    23,551 sharesLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3882407-4
  • ◆
    SVP, Global Ethics and ComplianceExecutivesGlaxoSmithKline plc
    0FCA-NSM
    50,108 sharesN/AISIN GB0009252882FCA-NSM:3879317-5
  • ◆
    SVP, Global Ethics and ComplianceExecutivesGlaxoSmithKline plc
    0FCA-NSM
    4,019 sharesN/AISIN GB0009252882FCA-NSM:3878373-6
  • ◆
    SVP, Global Ethics and ComplianceExecutivesGlaxoSmithKline plc
    0FCA-NSM
    68,441 sharesN/AISIN GB0009252882FCA-NSM:3878367-6
  • ◆
    SVP, Global Ethics and ComplianceExecutivesGlaxoSmithKline plc
    254 GBP0FCA-NSM
    20 shares@ £12.717London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3875131-4
  • ◆
    SVP, Global Ethics & ComplianceExecutivesGlaxoSmithKline plc
    3,832 GBP0FCA-NSM
    275 shares@ £13.934London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3851939-6
  • ◆
    SVP, Global Ethics & ComplianceExecutivesGlaxoSmithKline plc
    11,772 GBP0FCA-NSM
    837.932 shares@ £14.0488London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3850615-4
  • ◆
    SVP, Global Ethics & ComplianceExecutivesGlaxoSmithKline plc
    180 GBP0FCA-NSM
    13 shares@ £13.88London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3847478-0
  • ◆
    SVP, Global Ethics & ComplianceExecutivesGlaxoSmithKline plc
    264 GBP0FCA-NSM
    19 shares@ £13.8721London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3847444-4
  • ◆
    SVP, Global Ethics and ComplianceExecutivesGlaxoSmithKline plc
    249 GBP0FCA-NSM
    18 shares@ £13.8428London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3844188-4
  • ◆
    SVP, Global Ethics and ComplianceExecutivesGlaxoSmithKline plc
    252 GBP11FCA-NSM
    18 shares@ £14.02722.7% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3811317-4
  • ◆
    SVP, Global Ethics & ComplianceExecutivesGlaxoSmithKline plc
    8,996 GBP19FCA-NSM
    870 shares@ £10.3497.3% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3803557-1
  • ◆
    SVP, Global Ethics and ComplianceExecutivesGlaxoSmithKline plc
    263 GBP0FCA-NSM
    18 shares@ £14.6233London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3777599-4
  • ◆
    SVP, Global Ethics & ComplianceExecutivesGlaxoSmithKline plc
    3,792 GBP0FCA-NSM
    266 shares@ £14.254London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3748390-6
  • ◆
    SVP, Global Ethics & ComplianceExecutivesGlaxoSmithKline plc
    11,619 GBP0FCA-NSM
    806.806 shares@ £14.4008London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3746934-5
  • ◆
    SVP, Global Ethics and ComplianceExecutivesGlaxoSmithKline plc
    230 GBP0FCA-NSM
    16 shares@ £14.3994London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3746905-4

25 of 172 declarations